We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Trenzyme Licenses SEFEX Cell Line Technology from Celonic AG

News   Oct 09, 2015

 
Trenzyme Licenses SEFEX Cell Line Technology from Celonic AG
 
 
 

RELATED ARTICLES

T Cells Attack and Kill Dopamine-Producing Cells in Parkinson's disease

News

Researchers in Germany discover a potential new target for treating Parkinson's disease

READ MORE

Doctors Rely on More Than Just Data During a Diagnosis

News

Computer scientists examine how a doctor’s “gut feeling” influences how many tests they order for patients

READ MORE

CRISPR Screening Reveals Sickle Cell Disease Target

News

A key signaling protein, known as heme-regulated inhibitor (HRI), has been identified as a potential therapeutic target for the development of drugs to treat sickle cell disease, using a CRISPR screening approach.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE